Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19

Covid19 Clinical Trial

Official title: Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19

Status Completed

Clinical Trial Summary

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. The aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19.

Clinical Trial Description

The effects of COVID-19 on body systems and functions are still being investigated. ACE 2, which plays a key role in the entry of the COVID-19 virus into the cell, is also highly expressed in the ovary, uterus, vagina, and placenta in the female genital system, which can also pose a risk to female reproductive health. It has been examined that menstruation volume decreased or cycle lengthened in one-fifth of women who had COVID-19, and this condition was more intense in those who had severe COVID-19. Studies have shown that the possible effects of COVID-19 on the female genital system often remain theoretical hypotheses. In the literature, there was no study in which menstrual dysfunctions and secondary problems caused by the state of inactivity entering our lives during pandemic were discussed in a wide spectrum of women who had COVID-19. Therefore the aim of this study is to evaluate menstrual cycle-induced pain, fatigue and anxiety in women who suffered from COVID-19. ;

Related Conditions & MeSH terms

• Covid19
• Fatigue
• Menstrual Problem
• Menstruation Disturbances

• NCT number: NCT04806815
• Study type: Observational
• Source: Biruni University
• Status: Completed
• Start date: May 18, 2021
• Completion date: June 1, 2021